Extended Data Fig. 1: Kaplan-Meier estimate of time to first subsequent chemotherapy or death. | Nature Medicine

Extended Data Fig. 1: Kaplan-Meier estimate of time to first subsequent chemotherapy or death.

From: Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial

Extended Data Fig. 1

Treatment effects were compared using the stratified log-rank test; HRs and corresponding 95% CIs were estimated using the Cox proportional hazards model stratified by the presence of visceral metastasis (yes vs no) and menopausal status (postmenopausal vs premenopausal or perimenopausal). The P value is one-sided with no adjustment for multiplicity. HR = hazard ratio; NR = not reached.

Back to article page